Skip to main content

Advertisement

SpringerLink
Log in

Prognostic factors in patients with small cell lung carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Background The current prognosis in patients with small cell lung cancer (SCLC) is unsatisfactory, even though there have been considerable improvements in diagnosis and treatment. Methods We retrospectively analyzed all consecutive patients with small cell lung carcinoma between 1995 and 2007 in a Turkish chest hospital. A total of 116 SCLC patients initially presented with limited disease, while 92 small cell lung carcinoma patients were found to be extensive. Results The mean age of the patients (18 women and 190 men) was 56 years. The median survival was 74 weeks. Performance status, superior vena cava syndrome (SVCS), stage, elevated white blood cell count, elevated lactate dehidrogenase levels, short symptom duration (≤4 weeks) response to chemotherapy and bone metastasis were significant prognostic factors in univariate analysis. It was necessary for patients to receive at least three cycles of chemotherapy for a survival benefit. Cox proportional hazards model identified only stage, performance status and SVCS as independent prognostic factors. Conclusions Stage, performance status and SVCS were determined to be the most important prognostic factors for SCLC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gonlugur TE, Gonlugur U. Comorbidity as a prognostic factor in small cell lung cancer. Tumori. 2006;92:423–8.

    PubMed  Google Scholar 

  2. Tas F, et al. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer. Acta Oncol. 1999;38:1011–5.

    Article  CAS  PubMed  Google Scholar 

  3. The World Health Organization. The World Health Organization histological typing of lung tumors. Second edition. Am J Clin Pathol. 1982; 77:123–36.

    Google Scholar 

  4. Bulbul Y, Oztuna F, Topba M, Ozlu T. Survival analyses of patients with thoracic complications secondary to bronchial carcinoma at the time of diagnosis. Respiration. 2005;72:388–94.

    Article  PubMed  Google Scholar 

  5. Würschmidt F, Bünemann H, Heilmann HP. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys. 1995;33:77–82.

    PubMed  Google Scholar 

  6. Tai P, et al. Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment. BMC Cancer. 2007;7:31.

    Article  PubMed  Google Scholar 

  7. Christodolou C, et al. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study. Anticancer Res. 2002;22:3749–57.

    CAS  PubMed  Google Scholar 

  8. Bremnes RM, et al. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer. 2003;39:303–13.

    Article  PubMed  Google Scholar 

  9. Sagman U, et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol. 1991;9:1639–49.

    CAS  PubMed  Google Scholar 

  10. Paesmans M, et al. Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer. 2000;89:523–33.

    Article  CAS  PubMed  Google Scholar 

  11. Watine J. Prognostic factors for patients with small cell lung carcinoma. Cancer. 2002;94:576–8.

    Article  PubMed  Google Scholar 

  12. Quoix E, et al. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2000;30:127–34.

    Article  CAS  PubMed  Google Scholar 

  13. Stokkel MP, van Eck-Smit BL, Zwinderman AH, Willems LN, Pauwels EK. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma. J Cancer Res Clin Oncol. 1998;124:215–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kristjansen PE, Osterlind K, Hansen M. Detection of bone marrow relapse in patients with small cell carcinoma of the lung. Cancer. 1986;58:2538–41.

    Article  CAS  PubMed  Google Scholar 

  15. Cooper S, Spiro S. Small cell lung cancer: treatment review. Respirology. 2006;11:241–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Disease, Sureyyapasa Chest Disease and Thoracic Surgery Training and Research Hospital, Goktepe Sokak, No: 2/14, Feneryolu, Istanbul, Turkey

    S. Arinc, O. Devran, N. Erdal, F. Ece, M. Ertugrul, D. Derince, O. Oruc & A. Hazar

  2. Department of Chest Diseases, Cumhuriyet University Medical School, Sivas, Turkey

    U. Gonlugur

Authors
  1. S. Arinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Gonlugur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Devran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Erdal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Ece
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Ertugrul
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Derince
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. O. Oruc
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Hazar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Arinc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arinc, S., Gonlugur, U., Devran, O. et al. Prognostic factors in patients with small cell lung carcinoma. Med Oncol 27, 237–241 (2010). https://doi.org/10.1007/s12032-009-9198-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-009-9198-8

Keywords

Search

Navigation